tradingkey.logo

Transmedics Group Inc

TMDX
View Detailed Chart

142.880USD

-0.165-0.12%
Close 06/13, 16:00ETQuotes delayed by 15 min
4.83BMarket Cap
136.29P/E TTM

Transmedics Group Inc

142.880

-0.165-0.12%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.12%

5 Days

+2.75%

1 Month

+17.30%

6 Months

+122.35%

Year to Date

+129.16%

1 Year

+0.61%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 10 analysts
BUY
Current Rating
136.500
Target Price
-4.47%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Transmedics Group Inc
TMDX
10
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
32
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(2)
Neutral(1)
Buy(7)
Indicators
Sell(2)
Neutral(1)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.194
Buy
RSI(14)
81.982
Overbought
STOCH(KDJ)(9,3,3)
89.224
Overbought
ATR(14)
4.997
Low Volatility
CCI(14)
94.438
Neutral
Williams %R
10.397
Overbought
TRIX(12,20)
1.234
Sell
StochRSI(14)
77.482
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
141.813
Buy
MA10
136.620
Buy
MA20
130.772
Buy
MA50
107.124
Buy
MA100
88.341
Buy
MA200
96.466
Buy

News

More news coming soon, stay tuned...

Company

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEODr. Waleed H. Hassanein, M.D.
Websitehttps://www.transmedics.com/
KeyAI